Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications
Pedro Santos-Moreno,1 Gabriel-Santiago Rodríguez-Vargas,1 Susan Martínez,2 Linda Ibatá,2 Adriana Rojas-Villarraga3 1Rheumatology, Biomab IPS, Bogotá, Colombia; 2Epidemiology, Epithink Health Consulting, Bogotá, Colombia; 3Research Institute, Fundación Universitaria de Ciencias de la Salud–FUCS, Bogo...
Ausführliche Beschreibung
Autor*in: |
Santos-Moreno P [verfasserIn] Rodríguez-Vargas GS [verfasserIn] Martínez S [verfasserIn] Ibatá L [verfasserIn] Rojas-Villarraga A [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2022 |
---|
Schlagwörter: |
---|
Übergeordnetes Werk: |
In: Open Access Rheumatology: Research and Reviews - Dove Medical Press, 2009, (2022), Seite 255-267 |
---|---|
Übergeordnetes Werk: |
year:2022 ; pages:255-267 |
Links: |
---|
Katalog-ID: |
DOAJ08360992X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ08360992X | ||
003 | DE-627 | ||
005 | 20230311021949.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230311s2022 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)DOAJ08360992X | ||
035 | |a (DE-599)DOAJc395e6e1b57e47878bcd254baf37e214 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a RC925-935 | |
100 | 0 | |a Santos-Moreno P |e verfasserin |4 aut | |
245 | 1 | 0 | |a Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Pedro Santos-Moreno,1 Gabriel-Santiago Rodríguez-Vargas,1 Susan Martínez,2 Linda Ibatá,2 Adriana Rojas-Villarraga3 1Rheumatology, Biomab IPS, Bogotá, Colombia; 2Epidemiology, Epithink Health Consulting, Bogotá, Colombia; 3Research Institute, Fundación Universitaria de Ciencias de la Salud–FUCS, Bogotá, ColombiaCorrespondence: Pedro Santos-Moreno, Rheumatology, Biomab IPS, Calle 48 # 13-86, Bogotá, Colombia, Tel +57 320 8094232, Email pedrosantosmorenohotmail.comAim: Rheumatoid arthritis is a prevalent worldwide disease, associated with an increased risk of multiple metabolic abnormalities that generate a higher disease burden.Objective: To gather the available evidence on the epidemiology, pathophysiology, current perspectives, clinical implications and prognosis of metabolic abnormalities in patients with rheumatoid arthritis.Methods: This is a narrative literature review. Search was conducted in PubMed, OVID, and Taylor & Francis databases, using the following MeSH terms: “Arthritis Rheumatoid”, “Metabolic Diseases”, and “Metabolic Syndrome”.Results: This study describes the main metabolic manifestations of rheumatoid arthritis. Research has recognized that rheumatoid arthritis and metabolic abnormalities share pathophysiological mechanisms with an additive effect that increases cardiovascular risk. In that context, appropriate antirheumatic treatment can also impact on cardiovascular risk.Conclusion: There are metabolic abnormalities in rheumatoid arthritis patients that increase cardiovascular risk. Therefore, it is crucial to evaluate cardiovascular risk to provide appropriate comprehensive management to reduce morbidity and mortality in patients with this disease.Keywords: rheumatoid arthritis, metabolic diseases, cardiovascular diseases, metabolic syndrome | ||
650 | 4 | |a rheumatoid arthritis | |
650 | 4 | |a metabolic diseases | |
650 | 4 | |a cardiovascular diseases | |
650 | 4 | |a metabolic syndrome. | |
653 | 0 | |a Diseases of the musculoskeletal system | |
700 | 0 | |a Rodríguez-Vargas GS |e verfasserin |4 aut | |
700 | 0 | |a Martínez S |e verfasserin |4 aut | |
700 | 0 | |a Ibatá L |e verfasserin |4 aut | |
700 | 0 | |a Rojas-Villarraga A |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Open Access Rheumatology: Research and Reviews |d Dove Medical Press, 2009 |g (2022), Seite 255-267 |w (DE-627)606032002 |w (DE-600)2508169-X |x 1179156X |7 nnns |
773 | 1 | 8 | |g year:2022 |g pages:255-267 |
856 | 4 | 0 | |u https://doaj.org/article/c395e6e1b57e47878bcd254baf37e214 |z kostenfrei |
856 | 4 | 0 | |u https://www.dovepress.com/metabolic-abnormalities-cardiovascular-disease-and-metabolic-syndrome--peer-reviewed-fulltext-article-OARRR |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/1179-156X |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a GBV_ILN_11 | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_2003 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4700 | ||
951 | |a AR | ||
952 | |j 2022 |h 255-267 |
author_variant |
s m p smp r v g rvg m s ms i l il r v a rva |
---|---|
matchkey_str |
article:1179156X:2022----::eaoianraiisadoaclriesadeaoisnrmiauthuaodrhiiptetcre |
hierarchy_sort_str |
2022 |
callnumber-subject-code |
RC |
publishDate |
2022 |
allfields |
(DE-627)DOAJ08360992X (DE-599)DOAJc395e6e1b57e47878bcd254baf37e214 DE-627 ger DE-627 rakwb eng RC925-935 Santos-Moreno P verfasserin aut Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Pedro Santos-Moreno,1 Gabriel-Santiago Rodríguez-Vargas,1 Susan Martínez,2 Linda Ibatá,2 Adriana Rojas-Villarraga3 1Rheumatology, Biomab IPS, Bogotá, Colombia; 2Epidemiology, Epithink Health Consulting, Bogotá, Colombia; 3Research Institute, Fundación Universitaria de Ciencias de la Salud–FUCS, Bogotá, ColombiaCorrespondence: Pedro Santos-Moreno, Rheumatology, Biomab IPS, Calle 48 # 13-86, Bogotá, Colombia, Tel +57 320 8094232, Email pedrosantosmorenohotmail.comAim: Rheumatoid arthritis is a prevalent worldwide disease, associated with an increased risk of multiple metabolic abnormalities that generate a higher disease burden.Objective: To gather the available evidence on the epidemiology, pathophysiology, current perspectives, clinical implications and prognosis of metabolic abnormalities in patients with rheumatoid arthritis.Methods: This is a narrative literature review. Search was conducted in PubMed, OVID, and Taylor & Francis databases, using the following MeSH terms: “Arthritis Rheumatoid”, “Metabolic Diseases”, and “Metabolic Syndrome”.Results: This study describes the main metabolic manifestations of rheumatoid arthritis. Research has recognized that rheumatoid arthritis and metabolic abnormalities share pathophysiological mechanisms with an additive effect that increases cardiovascular risk. In that context, appropriate antirheumatic treatment can also impact on cardiovascular risk.Conclusion: There are metabolic abnormalities in rheumatoid arthritis patients that increase cardiovascular risk. Therefore, it is crucial to evaluate cardiovascular risk to provide appropriate comprehensive management to reduce morbidity and mortality in patients with this disease.Keywords: rheumatoid arthritis, metabolic diseases, cardiovascular diseases, metabolic syndrome rheumatoid arthritis metabolic diseases cardiovascular diseases metabolic syndrome. Diseases of the musculoskeletal system Rodríguez-Vargas GS verfasserin aut Martínez S verfasserin aut Ibatá L verfasserin aut Rojas-Villarraga A verfasserin aut In Open Access Rheumatology: Research and Reviews Dove Medical Press, 2009 (2022), Seite 255-267 (DE-627)606032002 (DE-600)2508169-X 1179156X nnns year:2022 pages:255-267 https://doaj.org/article/c395e6e1b57e47878bcd254baf37e214 kostenfrei https://www.dovepress.com/metabolic-abnormalities-cardiovascular-disease-and-metabolic-syndrome--peer-reviewed-fulltext-article-OARRR kostenfrei https://doaj.org/toc/1179-156X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2022 255-267 |
spelling |
(DE-627)DOAJ08360992X (DE-599)DOAJc395e6e1b57e47878bcd254baf37e214 DE-627 ger DE-627 rakwb eng RC925-935 Santos-Moreno P verfasserin aut Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Pedro Santos-Moreno,1 Gabriel-Santiago Rodríguez-Vargas,1 Susan Martínez,2 Linda Ibatá,2 Adriana Rojas-Villarraga3 1Rheumatology, Biomab IPS, Bogotá, Colombia; 2Epidemiology, Epithink Health Consulting, Bogotá, Colombia; 3Research Institute, Fundación Universitaria de Ciencias de la Salud–FUCS, Bogotá, ColombiaCorrespondence: Pedro Santos-Moreno, Rheumatology, Biomab IPS, Calle 48 # 13-86, Bogotá, Colombia, Tel +57 320 8094232, Email pedrosantosmorenohotmail.comAim: Rheumatoid arthritis is a prevalent worldwide disease, associated with an increased risk of multiple metabolic abnormalities that generate a higher disease burden.Objective: To gather the available evidence on the epidemiology, pathophysiology, current perspectives, clinical implications and prognosis of metabolic abnormalities in patients with rheumatoid arthritis.Methods: This is a narrative literature review. Search was conducted in PubMed, OVID, and Taylor & Francis databases, using the following MeSH terms: “Arthritis Rheumatoid”, “Metabolic Diseases”, and “Metabolic Syndrome”.Results: This study describes the main metabolic manifestations of rheumatoid arthritis. Research has recognized that rheumatoid arthritis and metabolic abnormalities share pathophysiological mechanisms with an additive effect that increases cardiovascular risk. In that context, appropriate antirheumatic treatment can also impact on cardiovascular risk.Conclusion: There are metabolic abnormalities in rheumatoid arthritis patients that increase cardiovascular risk. Therefore, it is crucial to evaluate cardiovascular risk to provide appropriate comprehensive management to reduce morbidity and mortality in patients with this disease.Keywords: rheumatoid arthritis, metabolic diseases, cardiovascular diseases, metabolic syndrome rheumatoid arthritis metabolic diseases cardiovascular diseases metabolic syndrome. Diseases of the musculoskeletal system Rodríguez-Vargas GS verfasserin aut Martínez S verfasserin aut Ibatá L verfasserin aut Rojas-Villarraga A verfasserin aut In Open Access Rheumatology: Research and Reviews Dove Medical Press, 2009 (2022), Seite 255-267 (DE-627)606032002 (DE-600)2508169-X 1179156X nnns year:2022 pages:255-267 https://doaj.org/article/c395e6e1b57e47878bcd254baf37e214 kostenfrei https://www.dovepress.com/metabolic-abnormalities-cardiovascular-disease-and-metabolic-syndrome--peer-reviewed-fulltext-article-OARRR kostenfrei https://doaj.org/toc/1179-156X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2022 255-267 |
allfields_unstemmed |
(DE-627)DOAJ08360992X (DE-599)DOAJc395e6e1b57e47878bcd254baf37e214 DE-627 ger DE-627 rakwb eng RC925-935 Santos-Moreno P verfasserin aut Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Pedro Santos-Moreno,1 Gabriel-Santiago Rodríguez-Vargas,1 Susan Martínez,2 Linda Ibatá,2 Adriana Rojas-Villarraga3 1Rheumatology, Biomab IPS, Bogotá, Colombia; 2Epidemiology, Epithink Health Consulting, Bogotá, Colombia; 3Research Institute, Fundación Universitaria de Ciencias de la Salud–FUCS, Bogotá, ColombiaCorrespondence: Pedro Santos-Moreno, Rheumatology, Biomab IPS, Calle 48 # 13-86, Bogotá, Colombia, Tel +57 320 8094232, Email pedrosantosmorenohotmail.comAim: Rheumatoid arthritis is a prevalent worldwide disease, associated with an increased risk of multiple metabolic abnormalities that generate a higher disease burden.Objective: To gather the available evidence on the epidemiology, pathophysiology, current perspectives, clinical implications and prognosis of metabolic abnormalities in patients with rheumatoid arthritis.Methods: This is a narrative literature review. Search was conducted in PubMed, OVID, and Taylor & Francis databases, using the following MeSH terms: “Arthritis Rheumatoid”, “Metabolic Diseases”, and “Metabolic Syndrome”.Results: This study describes the main metabolic manifestations of rheumatoid arthritis. Research has recognized that rheumatoid arthritis and metabolic abnormalities share pathophysiological mechanisms with an additive effect that increases cardiovascular risk. In that context, appropriate antirheumatic treatment can also impact on cardiovascular risk.Conclusion: There are metabolic abnormalities in rheumatoid arthritis patients that increase cardiovascular risk. Therefore, it is crucial to evaluate cardiovascular risk to provide appropriate comprehensive management to reduce morbidity and mortality in patients with this disease.Keywords: rheumatoid arthritis, metabolic diseases, cardiovascular diseases, metabolic syndrome rheumatoid arthritis metabolic diseases cardiovascular diseases metabolic syndrome. Diseases of the musculoskeletal system Rodríguez-Vargas GS verfasserin aut Martínez S verfasserin aut Ibatá L verfasserin aut Rojas-Villarraga A verfasserin aut In Open Access Rheumatology: Research and Reviews Dove Medical Press, 2009 (2022), Seite 255-267 (DE-627)606032002 (DE-600)2508169-X 1179156X nnns year:2022 pages:255-267 https://doaj.org/article/c395e6e1b57e47878bcd254baf37e214 kostenfrei https://www.dovepress.com/metabolic-abnormalities-cardiovascular-disease-and-metabolic-syndrome--peer-reviewed-fulltext-article-OARRR kostenfrei https://doaj.org/toc/1179-156X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2022 255-267 |
allfieldsGer |
(DE-627)DOAJ08360992X (DE-599)DOAJc395e6e1b57e47878bcd254baf37e214 DE-627 ger DE-627 rakwb eng RC925-935 Santos-Moreno P verfasserin aut Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Pedro Santos-Moreno,1 Gabriel-Santiago Rodríguez-Vargas,1 Susan Martínez,2 Linda Ibatá,2 Adriana Rojas-Villarraga3 1Rheumatology, Biomab IPS, Bogotá, Colombia; 2Epidemiology, Epithink Health Consulting, Bogotá, Colombia; 3Research Institute, Fundación Universitaria de Ciencias de la Salud–FUCS, Bogotá, ColombiaCorrespondence: Pedro Santos-Moreno, Rheumatology, Biomab IPS, Calle 48 # 13-86, Bogotá, Colombia, Tel +57 320 8094232, Email pedrosantosmorenohotmail.comAim: Rheumatoid arthritis is a prevalent worldwide disease, associated with an increased risk of multiple metabolic abnormalities that generate a higher disease burden.Objective: To gather the available evidence on the epidemiology, pathophysiology, current perspectives, clinical implications and prognosis of metabolic abnormalities in patients with rheumatoid arthritis.Methods: This is a narrative literature review. Search was conducted in PubMed, OVID, and Taylor & Francis databases, using the following MeSH terms: “Arthritis Rheumatoid”, “Metabolic Diseases”, and “Metabolic Syndrome”.Results: This study describes the main metabolic manifestations of rheumatoid arthritis. Research has recognized that rheumatoid arthritis and metabolic abnormalities share pathophysiological mechanisms with an additive effect that increases cardiovascular risk. In that context, appropriate antirheumatic treatment can also impact on cardiovascular risk.Conclusion: There are metabolic abnormalities in rheumatoid arthritis patients that increase cardiovascular risk. Therefore, it is crucial to evaluate cardiovascular risk to provide appropriate comprehensive management to reduce morbidity and mortality in patients with this disease.Keywords: rheumatoid arthritis, metabolic diseases, cardiovascular diseases, metabolic syndrome rheumatoid arthritis metabolic diseases cardiovascular diseases metabolic syndrome. Diseases of the musculoskeletal system Rodríguez-Vargas GS verfasserin aut Martínez S verfasserin aut Ibatá L verfasserin aut Rojas-Villarraga A verfasserin aut In Open Access Rheumatology: Research and Reviews Dove Medical Press, 2009 (2022), Seite 255-267 (DE-627)606032002 (DE-600)2508169-X 1179156X nnns year:2022 pages:255-267 https://doaj.org/article/c395e6e1b57e47878bcd254baf37e214 kostenfrei https://www.dovepress.com/metabolic-abnormalities-cardiovascular-disease-and-metabolic-syndrome--peer-reviewed-fulltext-article-OARRR kostenfrei https://doaj.org/toc/1179-156X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2022 255-267 |
allfieldsSound |
(DE-627)DOAJ08360992X (DE-599)DOAJc395e6e1b57e47878bcd254baf37e214 DE-627 ger DE-627 rakwb eng RC925-935 Santos-Moreno P verfasserin aut Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Pedro Santos-Moreno,1 Gabriel-Santiago Rodríguez-Vargas,1 Susan Martínez,2 Linda Ibatá,2 Adriana Rojas-Villarraga3 1Rheumatology, Biomab IPS, Bogotá, Colombia; 2Epidemiology, Epithink Health Consulting, Bogotá, Colombia; 3Research Institute, Fundación Universitaria de Ciencias de la Salud–FUCS, Bogotá, ColombiaCorrespondence: Pedro Santos-Moreno, Rheumatology, Biomab IPS, Calle 48 # 13-86, Bogotá, Colombia, Tel +57 320 8094232, Email pedrosantosmorenohotmail.comAim: Rheumatoid arthritis is a prevalent worldwide disease, associated with an increased risk of multiple metabolic abnormalities that generate a higher disease burden.Objective: To gather the available evidence on the epidemiology, pathophysiology, current perspectives, clinical implications and prognosis of metabolic abnormalities in patients with rheumatoid arthritis.Methods: This is a narrative literature review. Search was conducted in PubMed, OVID, and Taylor & Francis databases, using the following MeSH terms: “Arthritis Rheumatoid”, “Metabolic Diseases”, and “Metabolic Syndrome”.Results: This study describes the main metabolic manifestations of rheumatoid arthritis. Research has recognized that rheumatoid arthritis and metabolic abnormalities share pathophysiological mechanisms with an additive effect that increases cardiovascular risk. In that context, appropriate antirheumatic treatment can also impact on cardiovascular risk.Conclusion: There are metabolic abnormalities in rheumatoid arthritis patients that increase cardiovascular risk. Therefore, it is crucial to evaluate cardiovascular risk to provide appropriate comprehensive management to reduce morbidity and mortality in patients with this disease.Keywords: rheumatoid arthritis, metabolic diseases, cardiovascular diseases, metabolic syndrome rheumatoid arthritis metabolic diseases cardiovascular diseases metabolic syndrome. Diseases of the musculoskeletal system Rodríguez-Vargas GS verfasserin aut Martínez S verfasserin aut Ibatá L verfasserin aut Rojas-Villarraga A verfasserin aut In Open Access Rheumatology: Research and Reviews Dove Medical Press, 2009 (2022), Seite 255-267 (DE-627)606032002 (DE-600)2508169-X 1179156X nnns year:2022 pages:255-267 https://doaj.org/article/c395e6e1b57e47878bcd254baf37e214 kostenfrei https://www.dovepress.com/metabolic-abnormalities-cardiovascular-disease-and-metabolic-syndrome--peer-reviewed-fulltext-article-OARRR kostenfrei https://doaj.org/toc/1179-156X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2022 255-267 |
language |
English |
source |
In Open Access Rheumatology: Research and Reviews (2022), Seite 255-267 year:2022 pages:255-267 |
sourceStr |
In Open Access Rheumatology: Research and Reviews (2022), Seite 255-267 year:2022 pages:255-267 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
rheumatoid arthritis metabolic diseases cardiovascular diseases metabolic syndrome. Diseases of the musculoskeletal system |
isfreeaccess_bool |
true |
container_title |
Open Access Rheumatology: Research and Reviews |
authorswithroles_txt_mv |
Santos-Moreno P @@aut@@ Rodríguez-Vargas GS @@aut@@ Martínez S @@aut@@ Ibatá L @@aut@@ Rojas-Villarraga A @@aut@@ |
publishDateDaySort_date |
2022-01-01T00:00:00Z |
hierarchy_top_id |
606032002 |
id |
DOAJ08360992X |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ08360992X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230311021949.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230311s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ08360992X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJc395e6e1b57e47878bcd254baf37e214</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC925-935</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Santos-Moreno P</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Pedro Santos-Moreno,1 Gabriel-Santiago Rodríguez-Vargas,1 Susan Martínez,2 Linda Ibatá,2 Adriana Rojas-Villarraga3 1Rheumatology, Biomab IPS, Bogotá, Colombia; 2Epidemiology, Epithink Health Consulting, Bogotá, Colombia; 3Research Institute, Fundación Universitaria de Ciencias de la Salud–FUCS, Bogotá, ColombiaCorrespondence: Pedro Santos-Moreno, Rheumatology, Biomab IPS, Calle 48 &num; 13-86, Bogotá, Colombia, Tel +57 320 8094232, Email pedrosantosmorenohotmail.comAim: Rheumatoid arthritis is a prevalent worldwide disease, associated with an increased risk of multiple metabolic abnormalities that generate a higher disease burden.Objective: To gather the available evidence on the epidemiology, pathophysiology, current perspectives, clinical implications and prognosis of metabolic abnormalities in patients with rheumatoid arthritis.Methods: This is a narrative literature review. Search was conducted in PubMed, OVID, and Taylor & Francis databases, using the following MeSH terms: “Arthritis Rheumatoid”, “Metabolic Diseases”, and “Metabolic Syndrome”.Results: This study describes the main metabolic manifestations of rheumatoid arthritis. Research has recognized that rheumatoid arthritis and metabolic abnormalities share pathophysiological mechanisms with an additive effect that increases cardiovascular risk. In that context, appropriate antirheumatic treatment can also impact on cardiovascular risk.Conclusion: There are metabolic abnormalities in rheumatoid arthritis patients that increase cardiovascular risk. Therefore, it is crucial to evaluate cardiovascular risk to provide appropriate comprehensive management to reduce morbidity and mortality in patients with this disease.Keywords: rheumatoid arthritis, metabolic diseases, cardiovascular diseases, metabolic syndrome</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">rheumatoid arthritis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">metabolic diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">cardiovascular diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">metabolic syndrome.</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Diseases of the musculoskeletal system</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Rodríguez-Vargas GS</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Martínez S</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ibatá L</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Rojas-Villarraga A</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Open Access Rheumatology: Research and Reviews</subfield><subfield code="d">Dove Medical Press, 2009</subfield><subfield code="g">(2022), Seite 255-267</subfield><subfield code="w">(DE-627)606032002</subfield><subfield code="w">(DE-600)2508169-X</subfield><subfield code="x">1179156X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">year:2022</subfield><subfield code="g">pages:255-267</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/c395e6e1b57e47878bcd254baf37e214</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.dovepress.com/metabolic-abnormalities-cardiovascular-disease-and-metabolic-syndrome--peer-reviewed-fulltext-article-OARRR</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1179-156X</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="j">2022</subfield><subfield code="h">255-267</subfield></datafield></record></collection>
|
callnumber-first |
R - Medicine |
author |
Santos-Moreno P |
spellingShingle |
Santos-Moreno P misc RC925-935 misc rheumatoid arthritis misc metabolic diseases misc cardiovascular diseases misc metabolic syndrome. misc Diseases of the musculoskeletal system Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications |
authorStr |
Santos-Moreno P |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)606032002 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut aut aut |
collection |
DOAJ |
remote_str |
true |
callnumber-label |
RC925-935 |
illustrated |
Not Illustrated |
issn |
1179156X |
topic_title |
RC925-935 Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications rheumatoid arthritis metabolic diseases cardiovascular diseases metabolic syndrome |
topic |
misc RC925-935 misc rheumatoid arthritis misc metabolic diseases misc cardiovascular diseases misc metabolic syndrome. misc Diseases of the musculoskeletal system |
topic_unstemmed |
misc RC925-935 misc rheumatoid arthritis misc metabolic diseases misc cardiovascular diseases misc metabolic syndrome. misc Diseases of the musculoskeletal system |
topic_browse |
misc RC925-935 misc rheumatoid arthritis misc metabolic diseases misc cardiovascular diseases misc metabolic syndrome. misc Diseases of the musculoskeletal system |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Open Access Rheumatology: Research and Reviews |
hierarchy_parent_id |
606032002 |
hierarchy_top_title |
Open Access Rheumatology: Research and Reviews |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)606032002 (DE-600)2508169-X |
title |
Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications |
ctrlnum |
(DE-627)DOAJ08360992X (DE-599)DOAJc395e6e1b57e47878bcd254baf37e214 |
title_full |
Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications |
author_sort |
Santos-Moreno P |
journal |
Open Access Rheumatology: Research and Reviews |
journalStr |
Open Access Rheumatology: Research and Reviews |
callnumber-first-code |
R |
lang_code |
eng |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2022 |
contenttype_str_mv |
txt |
container_start_page |
255 |
author_browse |
Santos-Moreno P Rodríguez-Vargas GS Martínez S Ibatá L Rojas-Villarraga A |
class |
RC925-935 |
format_se |
Elektronische Aufsätze |
author-letter |
Santos-Moreno P |
author2-role |
verfasserin |
title_sort |
metabolic abnormalities, cardiovascular disease, and metabolic syndrome in adult rheumatoid arthritis patients: current perspectives and clinical implications |
callnumber |
RC925-935 |
title_auth |
Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications |
abstract |
Pedro Santos-Moreno,1 Gabriel-Santiago Rodríguez-Vargas,1 Susan Martínez,2 Linda Ibatá,2 Adriana Rojas-Villarraga3 1Rheumatology, Biomab IPS, Bogotá, Colombia; 2Epidemiology, Epithink Health Consulting, Bogotá, Colombia; 3Research Institute, Fundación Universitaria de Ciencias de la Salud–FUCS, Bogotá, ColombiaCorrespondence: Pedro Santos-Moreno, Rheumatology, Biomab IPS, Calle 48 # 13-86, Bogotá, Colombia, Tel +57 320 8094232, Email pedrosantosmorenohotmail.comAim: Rheumatoid arthritis is a prevalent worldwide disease, associated with an increased risk of multiple metabolic abnormalities that generate a higher disease burden.Objective: To gather the available evidence on the epidemiology, pathophysiology, current perspectives, clinical implications and prognosis of metabolic abnormalities in patients with rheumatoid arthritis.Methods: This is a narrative literature review. Search was conducted in PubMed, OVID, and Taylor & Francis databases, using the following MeSH terms: “Arthritis Rheumatoid”, “Metabolic Diseases”, and “Metabolic Syndrome”.Results: This study describes the main metabolic manifestations of rheumatoid arthritis. Research has recognized that rheumatoid arthritis and metabolic abnormalities share pathophysiological mechanisms with an additive effect that increases cardiovascular risk. In that context, appropriate antirheumatic treatment can also impact on cardiovascular risk.Conclusion: There are metabolic abnormalities in rheumatoid arthritis patients that increase cardiovascular risk. Therefore, it is crucial to evaluate cardiovascular risk to provide appropriate comprehensive management to reduce morbidity and mortality in patients with this disease.Keywords: rheumatoid arthritis, metabolic diseases, cardiovascular diseases, metabolic syndrome |
abstractGer |
Pedro Santos-Moreno,1 Gabriel-Santiago Rodríguez-Vargas,1 Susan Martínez,2 Linda Ibatá,2 Adriana Rojas-Villarraga3 1Rheumatology, Biomab IPS, Bogotá, Colombia; 2Epidemiology, Epithink Health Consulting, Bogotá, Colombia; 3Research Institute, Fundación Universitaria de Ciencias de la Salud–FUCS, Bogotá, ColombiaCorrespondence: Pedro Santos-Moreno, Rheumatology, Biomab IPS, Calle 48 # 13-86, Bogotá, Colombia, Tel +57 320 8094232, Email pedrosantosmorenohotmail.comAim: Rheumatoid arthritis is a prevalent worldwide disease, associated with an increased risk of multiple metabolic abnormalities that generate a higher disease burden.Objective: To gather the available evidence on the epidemiology, pathophysiology, current perspectives, clinical implications and prognosis of metabolic abnormalities in patients with rheumatoid arthritis.Methods: This is a narrative literature review. Search was conducted in PubMed, OVID, and Taylor & Francis databases, using the following MeSH terms: “Arthritis Rheumatoid”, “Metabolic Diseases”, and “Metabolic Syndrome”.Results: This study describes the main metabolic manifestations of rheumatoid arthritis. Research has recognized that rheumatoid arthritis and metabolic abnormalities share pathophysiological mechanisms with an additive effect that increases cardiovascular risk. In that context, appropriate antirheumatic treatment can also impact on cardiovascular risk.Conclusion: There are metabolic abnormalities in rheumatoid arthritis patients that increase cardiovascular risk. Therefore, it is crucial to evaluate cardiovascular risk to provide appropriate comprehensive management to reduce morbidity and mortality in patients with this disease.Keywords: rheumatoid arthritis, metabolic diseases, cardiovascular diseases, metabolic syndrome |
abstract_unstemmed |
Pedro Santos-Moreno,1 Gabriel-Santiago Rodríguez-Vargas,1 Susan Martínez,2 Linda Ibatá,2 Adriana Rojas-Villarraga3 1Rheumatology, Biomab IPS, Bogotá, Colombia; 2Epidemiology, Epithink Health Consulting, Bogotá, Colombia; 3Research Institute, Fundación Universitaria de Ciencias de la Salud–FUCS, Bogotá, ColombiaCorrespondence: Pedro Santos-Moreno, Rheumatology, Biomab IPS, Calle 48 # 13-86, Bogotá, Colombia, Tel +57 320 8094232, Email pedrosantosmorenohotmail.comAim: Rheumatoid arthritis is a prevalent worldwide disease, associated with an increased risk of multiple metabolic abnormalities that generate a higher disease burden.Objective: To gather the available evidence on the epidemiology, pathophysiology, current perspectives, clinical implications and prognosis of metabolic abnormalities in patients with rheumatoid arthritis.Methods: This is a narrative literature review. Search was conducted in PubMed, OVID, and Taylor & Francis databases, using the following MeSH terms: “Arthritis Rheumatoid”, “Metabolic Diseases”, and “Metabolic Syndrome”.Results: This study describes the main metabolic manifestations of rheumatoid arthritis. Research has recognized that rheumatoid arthritis and metabolic abnormalities share pathophysiological mechanisms with an additive effect that increases cardiovascular risk. In that context, appropriate antirheumatic treatment can also impact on cardiovascular risk.Conclusion: There are metabolic abnormalities in rheumatoid arthritis patients that increase cardiovascular risk. Therefore, it is crucial to evaluate cardiovascular risk to provide appropriate comprehensive management to reduce morbidity and mortality in patients with this disease.Keywords: rheumatoid arthritis, metabolic diseases, cardiovascular diseases, metabolic syndrome |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 |
title_short |
Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications |
url |
https://doaj.org/article/c395e6e1b57e47878bcd254baf37e214 https://www.dovepress.com/metabolic-abnormalities-cardiovascular-disease-and-metabolic-syndrome--peer-reviewed-fulltext-article-OARRR https://doaj.org/toc/1179-156X |
remote_bool |
true |
author2 |
Rodríguez-Vargas GS Martínez S Ibatá L Rojas-Villarraga A |
author2Str |
Rodríguez-Vargas GS Martínez S Ibatá L Rojas-Villarraga A |
ppnlink |
606032002 |
callnumber-subject |
RC - Internal Medicine |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
callnumber-a |
RC925-935 |
up_date |
2024-07-03T18:25:35.520Z |
_version_ |
1803583367961116672 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ08360992X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230311021949.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230311s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ08360992X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJc395e6e1b57e47878bcd254baf37e214</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC925-935</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Santos-Moreno P</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Pedro Santos-Moreno,1 Gabriel-Santiago Rodríguez-Vargas,1 Susan Martínez,2 Linda Ibatá,2 Adriana Rojas-Villarraga3 1Rheumatology, Biomab IPS, Bogotá, Colombia; 2Epidemiology, Epithink Health Consulting, Bogotá, Colombia; 3Research Institute, Fundación Universitaria de Ciencias de la Salud–FUCS, Bogotá, ColombiaCorrespondence: Pedro Santos-Moreno, Rheumatology, Biomab IPS, Calle 48 &num; 13-86, Bogotá, Colombia, Tel +57 320 8094232, Email pedrosantosmorenohotmail.comAim: Rheumatoid arthritis is a prevalent worldwide disease, associated with an increased risk of multiple metabolic abnormalities that generate a higher disease burden.Objective: To gather the available evidence on the epidemiology, pathophysiology, current perspectives, clinical implications and prognosis of metabolic abnormalities in patients with rheumatoid arthritis.Methods: This is a narrative literature review. Search was conducted in PubMed, OVID, and Taylor & Francis databases, using the following MeSH terms: “Arthritis Rheumatoid”, “Metabolic Diseases”, and “Metabolic Syndrome”.Results: This study describes the main metabolic manifestations of rheumatoid arthritis. Research has recognized that rheumatoid arthritis and metabolic abnormalities share pathophysiological mechanisms with an additive effect that increases cardiovascular risk. In that context, appropriate antirheumatic treatment can also impact on cardiovascular risk.Conclusion: There are metabolic abnormalities in rheumatoid arthritis patients that increase cardiovascular risk. Therefore, it is crucial to evaluate cardiovascular risk to provide appropriate comprehensive management to reduce morbidity and mortality in patients with this disease.Keywords: rheumatoid arthritis, metabolic diseases, cardiovascular diseases, metabolic syndrome</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">rheumatoid arthritis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">metabolic diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">cardiovascular diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">metabolic syndrome.</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Diseases of the musculoskeletal system</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Rodríguez-Vargas GS</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Martínez S</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ibatá L</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Rojas-Villarraga A</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Open Access Rheumatology: Research and Reviews</subfield><subfield code="d">Dove Medical Press, 2009</subfield><subfield code="g">(2022), Seite 255-267</subfield><subfield code="w">(DE-627)606032002</subfield><subfield code="w">(DE-600)2508169-X</subfield><subfield code="x">1179156X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">year:2022</subfield><subfield code="g">pages:255-267</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/c395e6e1b57e47878bcd254baf37e214</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.dovepress.com/metabolic-abnormalities-cardiovascular-disease-and-metabolic-syndrome--peer-reviewed-fulltext-article-OARRR</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1179-156X</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="j">2022</subfield><subfield code="h">255-267</subfield></datafield></record></collection>
|
score |
7.400529 |